Skip to main content

Entrectinib

Placeholder slot
 (en-TREK-tih-nib)

This page contains brief information about entrectinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Rozlytrek
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Entrectinib is approved to treat:

¹This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that entrectinib provides a clinical benefit in these patients.

Entrectinib is also being studied in the treatment of other types of cancer.

More About Entrectinib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

FDA Approves Entrectinib Based on Tumor Genetics Rather Than Cancer Type

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Entrectinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: